A Phase Ii Study To Investigate The Efficacy Of Shortterm Everolimus In Addition To Post-Transplant Cyclophosphamide As Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation (Octet-Ever)

ONCOLOGY RESEARCH AND TREATMENT(2020)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要